Search Results - "Rajalekshmy, Kamalalayan Raghavan"

Flow Cytometry Based MRD and Its Impact on Survival Outcome in Children and Young Adults with ALL: A Prospective Study from a Tertiary Cancer Centre in Southern India by Panda, Soumya Surath, Radhakrishnan, Venkatraman, Ganesan, Prasanth, Rajendranath, Rejiv, Ganesan, Trivadi S., Rajalekshmy, Kamalalayan Raghavan, Bhola, Rajesh Kumar, Das, Hemlata, Sagar, Tenali Gnana

“…Presence of minimal residual disease (MRD) following induction chemotherapy is a well-recognized risk factor to predict relapse in acute lymphoblastic leukemia…”
Get full text

Acute lymphoblastic leukemia: A single center experience with Berlin, Frankfurt, and Munster-95 protocol by Radhakrishnan, Venkatraman, Gupta, Sumant, Ganesan, Prasanth, Rajendranath, Rejiv, Ganesan, Trivadi S., Rajalekshmy, Kamalalayan Raghavan, Sagar, Tenali Gnana

“…Abstract Background: There is a paucity of data on the outcome following the treatment for acute lymphoblastic leukemia (ALL) from developing countries…”
Get full text

Immunophenotypic analysis of T-cell acute lymphoblastic leukaemia in Madras, India by Rajalekshmy, Kamalalayam Raghavan, Abitha, Arcot Radhakrishnan, Pramila, Radhakrishnan, Gnanasagar, Tenali, Shanta, Viswanathan

“…Immunophenotypic analysis of 285 newly diagnosed previously untreated, unselected, acute lymphoblastic leukaemia cases carried out at the Cancer Institute…”
Get full text